Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Multiple Sclerosis

  Free Subscription


1 AJNR Am J Neuroradiol
1 Ann Neurol
2 BMC Neurol
1 Clin Ther
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 Lancet Neurol
2 Mult Scler
2 Nat Rev Neurol
2 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJNR Am J Neuroradiol

  1. KALININ I, Makshakov G, Evdoshenko E
    The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2020 May 7. pii: ajnr.A6513. doi: 10.3174/ajnr.A6513.
    PubMed         Abstract available

    Ann Neurol

  2. AMOR S, Baker D, Khoury SJ, Schmierer K, et al
    SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad.
    Ann Neurol. 2020 May 8. doi: 10.1002/ana.25770.
    PubMed         Abstract available

    BMC Neurol

  3. CIAMPI E, Uribe-San-Martin R, Carcamo C, Cruz JP, et al
    Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial.
    BMC Neurol. 2020;20:173.
    PubMed         Abstract available

  4. ALMASI-HASHIANI A, Sahraian MA, Eskandarieh S
    Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
    BMC Neurol. 2020;20:169.
    PubMed         Abstract available

    Clin Ther

  5. SANCHEZ MARTINEZ I, Cerdan Sanchez M, Lopez Roman J, Iniesta Martinez F, et al
    Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis.
    Clin Ther. 2020 Apr 30. pii: S0149-2918(20)30132.
    PubMed         Abstract available

    J Neurol

  6. COLOMBO C, Confalonieri P, Rovaris M, La Mantia L, et al
    The IN-DEEP project "INtegrating and Deriving Evidence, Experiences, Preferences": a web information model on magnetic resonance imaging for people with multiple sclerosis.
    J Neurol. 2020 May 2. pii: 10.1007/s00415-020-09864.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  7. ABRAHAMYAN S, Eberspacher B, Hoshi MM, Aly L, et al
    Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2020 May 5. pii: jnnp-2020-322941.
    PubMed         Abstract available


    Progress in Multiple Sclerosis Research: An Example of Bedside to Bench.
    JAMA. 2020 May 7. pii: 2765943. doi: 10.1001/jama.2020.1522.

    Lancet Neurol

    An Italian programme for COVID-19 infection in multiple sclerosis.
    Lancet Neurol. 2020 Apr 30. pii: S1474-4422(20)30147.

    Mult Scler

  10. LUNEMANN JD, Diaz-Diaz J, Stankoff B, Young C, et al
    Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019).
    Mult Scler. 2020 May 4:1352458520918377. doi: 10.1177/1352458520918377.
    PubMed         Abstract available

  11. BOSE G, Thebault S, Rush CA, Atkins HL, et al
    Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
    Mult Scler. 2020 May 4:1352458520917936. doi: 10.1177/1352458520917936.
    PubMed         Abstract available

    Nat Rev Neurol

  12. DELUCA J, Chiaravalloti ND, Sandroff BM
    Treatment and management of cognitive dysfunction in patients with multiple sclerosis.
    Nat Rev Neurol. 2020 May 5. pii: 10.1038/s41582-020-0355.
    PubMed         Abstract available

    NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis.
    Nat Rev Neurol. 2020 May 4. pii: 10.1038/s41582-020-0366.

    Rev Neurol (Paris)

    Should spinal cord MRI be systematically performed for diagnosis and follow-up of multiple sclerosis? Synthesis.
    Rev Neurol (Paris). 2020 Apr 29. pii: S0035-3787(20)30498.

  15. KERBRAT A, Edan G
    Should spinal cord MRI be systematically performed for diagnosis and follow up of multiple sclerosis? Yes.
    Rev Neurol (Paris). 2020 Apr 29. pii: S0035-3787(20)30496.

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.